Filing Details
- Accession Number:
- 0000950170-24-076379
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-21 17:59:55
- Reporting Period:
- 2024-06-20
- Accepted Time:
- 2024-06-21 17:59:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1593899 | Atea Pharmaceuticals Inc. | AVIR | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1508458 | Bruce Polsky | 225 Franklin Street Suite 2100 Boston MA 02110 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-06-20 | 17,544 | $3.49 | 65,606 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Acquisiton | 2024-06-21 | 29,600 | $0.00 | 29,600 | $0.00 |
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2024-06-21 | 41,200 | $0.00 | 41,200 | $3.44 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
29,600 | No | 4 | A | Direct | ||
41,200 | 2034-06-20 | No | 4 | A | Direct |
Footnotes
- The shares were sold solely to cover taxes upon the vesting of restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.43 to $3.53, inclusive.
- Restricted stock units convert into common stock on a one-for-one basis.
- The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
- The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 21, 2024, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date.